Chemed Long Term Debt 2012-2026 | CHE
Chemed long term debt from 2012 to 2026. Long term debt can be defined as the sum of all long term debt fields.
- Chemed long term debt for the quarter ending March 31, 2026 was $0M, a 0% increase year-over-year.
- Chemed long term debt for 2024 was $0B, a 0% decline from 2023.
- Chemed long term debt for 2023 was $0B, a 100% decline from 2022.
- Chemed long term debt for 2022 was $0.093B, a 50% decline from 2021.
|
Chemed Annual Long Term Debt (Millions of US $) |
|
|---|---|
| 2024 | |
| 2023 | |
| 2022 | $93 |
| 2021 | $185 |
| 2020 | |
| 2019 | $90 |
| 2018 | $89 |
| 2017 | $91 |
| 2016 | $100 |
| 2015 | $84 |
| 2014 | $141 |
| 2013 | |
| 2012 | $175 |
| 2011 | $167 |
|
Chemed Quarterly Long Term Debt (Millions of US $) |
|
|---|---|
| 2025-09-30 | |
| 2025-06-30 | |
| 2025-03-31 | |
| 2024-12-31 | |
| 2024-09-30 | |
| 2024-06-30 | |
| 2024-03-31 | |
| 2023-12-31 | |
| 2023-09-30 | |
| 2023-06-30 | |
| 2023-03-31 | $16 |
| 2022-12-31 | $93 |
| 2022-09-30 | $96 |
| 2022-06-30 | $112 |
| 2022-03-31 | $120 |
| 2021-12-31 | $185 |
| 2021-09-30 | |
| 2021-06-30 | |
| 2021-03-31 | |
| 2020-12-31 | |
| 2020-09-30 | |
| 2020-06-30 | |
| 2020-03-31 | $160 |
| 2019-12-31 | $90 |
| 2019-09-30 | $130 |
| 2019-06-30 | $85 |
| 2019-03-31 | $100 |
| 2018-12-31 | $89 |
| 2018-09-30 | $130 |
| 2018-06-30 | $103 |
| 2018-03-31 | $133 |
| 2017-12-31 | $91 |
| 2017-09-30 | $73 |
| 2017-06-30 | $115 |
| 2017-03-31 | $138 |
| 2016-12-31 | $100 |
| 2016-09-30 | $103 |
| 2016-06-30 | $140 |
| 2016-03-31 | $127 |
| 2015-12-31 | $84 |
| 2015-09-30 | $131 |
| 2015-06-30 | $153 |
| 2015-03-31 | $154 |
| 2014-12-31 | $141 |
| 2014-09-30 | $153 |
| 2014-06-30 | $155 |
| 2014-03-31 | |
| 2013-12-31 | |
| 2013-09-30 | |
| 2013-06-30 | |
| 2013-03-31 | $177 |
| 2012-12-31 | $175 |
| 2012-09-30 | $173 |
| 2012-06-30 | $171 |
| 2012-03-31 | $169 |
| 2011-12-31 | $167 |
| 2011-09-30 | $165 |
| 2011-06-30 | $163 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical - Outpatient & Home Care | $5.639B | $2.530B |
| Chemed Corporation purchases, operates and divests subsidiaries engaged in diverse business activities. The company's operating businesses are managed on a decentralized basis. Chemed currently operates as two wholly-owned subsidiaries: VITAS Healthcare and Roto-Rooter. VITAS Healthcare segment provides hospice and palliative care services for patients with terminal illnesses. VITAS offer all levels of hospice care in a given market, including routine home care, inpatient care and continuous care. Roto-Rooter segment provides plumbing and drain-cleaning services to both residential and commercial customers. It provides repair and maintenance services to residential and commercial accounts using the Roto-Rooter registered service marks. Such services include plumbing and sewer, drain and pipe cleaning. They are delivered through company-owned and operated territories, independent contractor-operated territories and franchised locations. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Fresenius SE (FSNUY) | Germany | $29.514B | 13.37 |
| Quest Diagnostics (DGX) | United States | $21.197B | 19.44 |
| Elanco Animal Health (ELAN) | United States | $11.500B | 24.35 |
| Encompass Health (EHC) | United States | $10.662B | 19.64 |
| DaVita (DVA) | United States | $10.023B | 13.82 |
| Option Care Health (OPCH) | United States | $4.553B | 18.71 |
| RadNet (RDNT) | United States | $4.302B | 142.13 |
| LifeStance Health (LFST) | United States | $2.495B | 320.00 |
| Addus HomeCare (ADUS) | United States | $1.719B | 16.61 |
| Astrana Health (ASTH) | United States | $1.536B | 31.40 |
| Aveanna Healthcare Holdings (AVAH) | United States | $1.353B | 12.20 |
| U.S Physical Therapy (USPH) | United States | $1.157B | 29.19 |
| Pennant (PNTG) | United States | $1.072B | 31.31 |
| Daxor (DXR) | United States | $0.048B | 0.00 |
| MEDIROM Healthcare Technologies (MRM) | Japan | $0.032B | 0.00 |
| Psychemedics (PMD) | United States | $0.000B | 0.00 |